In vitro generation of monocyte-derived macrophages under serum-free conditions improves their tumor promoting functions

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Rey Giraud, Flora ^a,b   Hafner, Mathias ^b   Ries, Carola H ^a  

^a ROCHE DIAGNOSTICS GMBH   (Germany)

^b MANNHEIM UNIVERSITY OF APPLIED SCIENCES   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 20; INTERLEUKIN 4; LIPOPOLYSACCHARIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MACROPHAGE ACTIVATION; MONOCYTE DERIVED MACROPHAGE; PHAGOCYTOSIS; PROTEIN EXPRESSION; SERUM; TUMOR PROMOTION;

CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SHAPE; CELL TRANSFORMATION, NEOPLASTIC; CHEMOKINES; CULTURE MEDIA, CONDITIONED; CULTURE MEDIA, SERUM-FREE; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; PHAGOCYTOSIS; RECEPTORS, CELL SURFACE;

EID: 84864720266     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042656     Document Type: Article

References (34)

1. Murray PJ, Wynn TA, ((2011)) Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11: 723-737.
2. Shi C, Pamer EG, ((2011)) Monocyte recruitment during infection and inflammation. Nat Rev Immunol 11: 762-774.
3. Bingle L, Brown NJ, Lewis CE, ((2002)) The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 196: 254-265.
4. Martinez FO, Sica A, Mantovani A, Locati M, ((2008)) Macrophage activation and polarization. Front Biosci 13: 453-461.
5. Mosser DM, Edwards JP, ((2008)) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969.
6. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, et al. ((2010)) Development of monocytes, macrophages, and dendritic cells. Science 327: 656-661.
7. Porcheray F, Viaud S, Rimaniol AC, Leone C, Samah B, et al. ((2005)) Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 142: 481-489.
8. Heusinkveld M, de Vos van Steenwijk PJ, Goedemans R, Ramwadhdoebe TH, Gorter A, et al. ((2011)) M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells. J Immunol 187: 1157-1165.
9. Qian BZ, Pollard JW, ((2010)) Macrophage diversity enhances tumor progression and metastasis. Cell 141: 39-51.
10. Biswas SK, Sica A, Lewis CE, ((2008)) Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J Immunol 180: 2011-2017.
11. Delneste Y, Charbonnier P, Herbault N, Magistrelli G, Caron G, et al. ((2003)) Interferon-gamma switches monocyte differentiation from dendritic cells to macrophages. Blood 101: 143-150.
12. Bonecchi R, Facchetti F, Dusi S, Luini W, Lissandrini D, et al. ((2000)) Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes. J Immunol 164: 3862-3869.
13. Way KJ, Dinh H, Keene MR, White KE, Clanchy FI, et al. ((2009)) The generation and properties of human macrophage populations from hemopoietic stem cells. J Leukoc Biol 85: 766-778.
14. Verreck FA, de BT, Langenberg DM, Hoeve MA, Kramer M, et al. ((2004)) Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci U S A 101: 4560-4565.
15. Smith W, Feldmann M, Londei M, ((1998)) Human macrophages induced in vitro by macrophage colony-stimulating factor are deficient in IL-12 production. Eur J Immunol 28: 2498-2507.
16. Palucka KA, Taquet N, Sanchez-Chapuis F, Gluckman JC, ((1998)) Dendritic cells as the terminal stage of monocyte differentiation. J Immunol 160: 4587-4595.
17. Becker S, Daniel EG, ((1990)) Antagonistic and additive effects of IL-4 and interferon-gamma on human monocytes and macrophages: effects on Fc receptors, HLA-D antigens, and superoxide production. Cell Immunol 129: 351-362.
18. Varin A, Gordon S, ((2009)) Alternative activation of macrophages: immune function and cellular biology. Immunobiology 214: 630-641.
19. Koning N, van EM, Pouwels W, Brouwer MS, Voehringer D, et al. ((2010)) Expression of the inhibitory CD200 receptor is associated with alternative macrophage activation. J Innate Immun 2: 195-200.
20. Buechler C, Ritter M, Orso E, Langmann T, Klucken J, et al. ((2000)) Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol 67: 97-103.
21. Cairo G, Locati M, Mantovani A, ((2010)) Control of iron homeostasis as a key component of macrophage polarization. Haematologica 95: 1801-1803.
22. Corna G, Campana L, Pignatti E, Castiglioni A, Tagliafico E, et al. ((2010)) Polarization dictates iron handling by inflammatory and alternatively activated macrophages. Haematologica 95: 1814-1822.
23. Mantovani A, Locati M, Vecchi A, Sozzani S, Allavena P, ((2001)) Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol 22: 328-336.
24. Munn DH, Cheung NK, ((1995)) Antibody-independent phagocytosis of tumor cells by human monocyte-derived macrophages cultured in recombinant macrophage colony-stimulating factor. Cancer Immunol Immunother 41: 46-52.
25. Kawamura K, Komohara Y, Takaishi K, Katabuchi H, Takeya M, ((2009)) Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors. Pathol Int 59: 300-305.
26. Kamper P, Bendix K, Hamilton-Dutoit S, Honore B, Nyengaard JR, et al. ((2011)) Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma. Haematologica 96: 269-276.
27. Komohara Y, Hasita H, Ohnishi K, Fujiwara Y, Suzu S, et al. ((2011)) Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma. Cancer Sci 102: 1424-1431.
28. Recalcati S, Locati M, Marini A, Santambrogio P, Zaninotto F, et al. ((2010)) Differential regulation of iron homeostasis during human macrophage polarized activation 3. Eur J Immunol 40: 824-835.
29. Beatty GL, Chiorean EG, Fishman MP, Saboury B, Teitelbaum UR, et al. ((2011)) CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science 331: 1612-1616.
30. Balkwill F, ((2009)) Tumour necrosis factor and cancer. Nat Rev Cancer 9: 361-371.
31. Sica A, Porta C, Riboldi E, Locati M, ((2010)) Convergent pathways of macrophage polarization: The role of B cells. Eur J Immunol 40: 2131-2133.
32. Daigneault M, Preston JA, Marriott HM, Whyte MK, Dockrell DH, ((2010)) The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One 5: e8668.
33. Leidi M, Gotti E, Bologna L, Miranda E, Rimoldi M, et al. ((2009)) M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro. J Immunol 182: 4415-4422.
34. Hume DA, MacDonald KP, ((2012)) Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling 1. Blood 119: 1810-1820.